Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Neoplasms 6Fatigue 6Pain 4Anxiety Disorders 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Hematologic Neoplasms 2Genital Neoplasms, Female 2Colorectal Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vomiting 1Vaginal Neoplasms 1Signs and Symptoms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Nausea 1Leukemia, Myeloid, Acute 1Leukemia 1Fatigue Syndrome, Chronic 1Epilepsy 1Endometrial Neoplasms 1Depression 1Congenital Abnormalities 1Caregiver Burden 1Cancer Pain 1

Interventions

Docetaxel 292Prednisone 240enzalutamide 193Leuprolide 185Radiotherapy 179Abiraterone Acetate 169Magnetic Resonance Spectroscopy 163bicalutamide 141Goserelin 138Androgen Antagonists 121acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108Radiosurgery 108apalutamide 92gallium 68 PSMA-11 81abiraterone 81Specimen Handling 73darolutamide 65Surveys and Questionnaires 64Gonadotropin-Releasing Hormone 63Triptorelin Pamoate 58Radiation 57Biopsy 57Brachytherapy 54cabazitaxel 52Standard of Care 51Radiotherapy, Intensity-Modulated 51Zoledronic Acid 50pembrolizumab 49luprolide acetate gel depot 49Flutamide 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Therapeutic Touch × Clear all
NCT00207259 2017-07-13

Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial

Brigham and Women's Hospital

Phase NA Completed
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT00065208 2012-09-24

Reiki/Energy Healing in Prostate Cancer

The Cleveland Clinic

Phase 1/2 Completed
79 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡